PHCCC is a research drug which acts as a glutamate receptor ligand, particularly being a positive allosteric modulator at the mGluR4 subtype,[1] as well as an agonist at mGluR6.[2] It has anxiolytic effects in animal studies.[3] PHCCC and similar drugs have been suggested as novel treatments for Parkinson's disease.[4]
Identifiers | |
---|---|
| |
PubChem CID |
|
Chemical and physical data | |
Formula | C17H14N2O3 |
Molar mass | 294.310 g·mol−1 |
3D model (JSmol) |
|
| |
(verify) |